BAM
STML

Bullseye Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Bullseye Asset Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-186,726
Closed -$904K – 100
2020
Q1 		$904K Buy
186,726
+63,529
+52% +$412K 1.08% 34
2019
Q4 		$1.31M Buy
+123,197
New +$1.22M 1.27% 36

Bullseye Asset Management's STML Position: Q2 2020 in Review

Bullseye Asset Management sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 186,726 shares — an estimated $904K sold.

Bullseye Asset Management first reported a position in STML in Q4 2019 and held it in 2 quarters. The position peaked at $1.31M in Q4 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Bullseye Asset Management reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Bullseye Asset Management sold 186,726 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $904K.
  • Bullseye Asset Management first reported a position in Stemline Therapeutics, Inc. in Q4 2019 and held it in 2 quarters.
  • Bullseye Asset Management's Stemline Therapeutics, Inc. position peaked at $1.31M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Bullseye Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.